Clinical Trial Update: Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating neoadjuvant chemo-immunotherapy followed by surgical resection for locally advanced non-small cell lung cancer with N3 ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Georgetown University | Conditions: Non-small Cell Lung Cancer Stage III | Phase 2 | Status: RECRUITING